Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKingfisher Regulatory News (KGF)

Share Price Information for Kingfisher (KGF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 249.00
Bid: 248.80
Ask: 248.90
Change: -3.90 (-1.54%)
Spread: 0.10 (0.04%)
Open: 252.00
High: 252.40
Low: 248.50
Prev. Close: 252.90
KGF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share repurchase programme – Fourth Tranche

23 Mar 2022 07:00

RNS Number : 6752F
Kingfisher PLC
23 March 2022
 

KINGFISHER PLC

Share repurchase programme - Fourth Tranche

 

23 March 2022: Kingfisher plc (the "Company" or "Kingfisher") announces that it has instructed Goldman Sachs International ("Goldman Sachs") in relation to a non-discretionary programme to purchase its shares for cancellation, during the period which will commence today and end no later than 27 May 2022 (the "Tranche"). Goldman Sachs will act as principal for the on-sale of such shares to the Company and will make its trading decisions concerning the timing of the purchases of the Company's ordinary shares independently of the Company.

The maximum amount allocated to the Tranche (excluding expenses) will be no greater than £75 million (Note 1). The purpose of the Tranche is to reduce the share capital of the Company. As such, the Company will cancel any ordinary shares purchased. This is the fourth tranche of an overall commitment by the Company to purchase £300 million of its shares for cancellation, as announced on 21 September 2021 (the "Programme").

Any acquisitions under the Programme will be carried out within certain pre-set parameters, and in accordance with the Company's general authority to repurchase shares, the EU Market Abuse Regulation (596/2014) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and Chapter 12 of the Listing Rules. The Company confirms that it currently has no unpublished price sensitive information.

For the avoidance of doubt, no repurchases will be made in respect of the Company's American Depositary Receipts.

Note 1. The maximum number of shares that the Company may purchase would be 141,911,376 ordinary shares of 15 5/7 pence each, in line with the authority granted to Kingfisher by shareholders at the Company's Annual General Meeting on 30 June 2021 and taking in to account the 69,211,867 shares purchased and cancelled during the first, second and third tranches completed on 22 November 2021, 21 January 2022, and 4 March 2022 respectively.

 

Contacts

Tel:

Email:

Company Secretary

+44 (0) 7768 806248

secretariat@kingfisher.com

Investor Relations

+44 (0) 20 7644 1082

investorenquiries@kingfisher.com

Treasury

+44 (0) 20 7644 1170

treasury@kingfisher.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFZGZFGZDGZZZ
Date   Source Headline
26th Jun 202011:40 amRNSAnnual Financial Report & Notice of AGM
18th Jun 20202:32 pmRNSDirector/PDMR Shareholding
17th Jun 20207:00 amRNSFinal Results - (Part 2 of 2)
17th Jun 20207:00 amRNSFinal Results - (Part 1 of 2)
16th Jun 20202:52 pmRNSDirector/PDMR Shareholding
4th Jun 20205:00 pmRNS2019/20 Full Year Results Announcement Date
2nd Jun 20208:53 amRNSBlock listing Interim Review
1st Jun 202012:12 pmRNSTotal Voting Rights
18th May 20202:58 pmRNSDirector/PDMR Shareholding
13th May 20204:37 pmRNSHolding(s) in Company
12th May 20207:00 amRNSCompany Update
5th May 202010:54 amRNSTotal Voting Rights
27th Apr 20202:41 pmRNSDisclosure of Rights of Securities
22nd Apr 20203:18 pmRNSHolding(s) in Company
16th Apr 20203:06 pmRNSDirector/PDMR Shareholding
1st Apr 20202:49 pmRNSTotal Voting Rights
26th Mar 20209:28 amRNSDirector Declaration
23rd Mar 20207:00 amRNSFCA moratorium - preliminary financial statements
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20208:57 amRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSCOVID-19 update
2nd Mar 20204:00 pmRNSTotal Voting Rights
20th Feb 20202:30 pmRNSDirector/PDMR Shareholding
3rd Feb 20209:48 amRNSTotal Voting Rights
22nd Jan 20202:44 pmRNSDirector/PDMR Shareholding
20th Jan 20202:00 pmRNSHolding(s) in Company
2nd Jan 202011:00 amRNSTotal Voting Rights
17th Dec 201911:18 amRNSDirector/PDMR Shareholding
12th Dec 20191:30 pmRNSHolding(s) in Company
9th Dec 201912:30 pmRNSHolding(s) in Company
2nd Dec 201910:02 amRNSTotal Voting Rights
27th Nov 20194:48 pmRNSDirectorate Change
26th Nov 20192:03 pmRNSDirector/PDMR Shareholding
22nd Nov 201911:00 amRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSQ3 Trading Update
12th Nov 20193:55 pmRNSDirector/PDMR Shareholding
12th Nov 20191:00 pmRNSHolding(s) in Company
6th Nov 20199:19 amRNSBlock listing Interim Review
4th Nov 20191:44 pmRNSDirector/PDMR Shareholding
1st Nov 20193:36 pmRNSTotal Voting Rights
23rd Oct 20195:20 pmRNSDirector/PDMR Shareholding
22nd Oct 20193:29 pmRNSDirector/PDMR Shareholding
21st Oct 201910:21 amRNSDirector Declaration
16th Oct 20191:00 pmRNSDirector/PDMR Shareholding
9th Oct 20197:00 amRNSDirectorate Change
4th Oct 20193:43 pmRNSHolding(s) in Company
1st Oct 20192:25 pmRNSDirector/PDMR Shareholding
1st Oct 201910:25 amRNSTotal Voting Rights
18th Sep 20195:11 pmRNSEMTN Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.